North central cancer treatment group Phase i trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme

Jann N. Sarkaria, Evanthia Galanis, Wenting Wu, Patrick J. Peller, Caterina Giannini, Paul D. Brown, Joon H. Uhm, Steven McGraw, Kurt A. Jaeckle, Jan C. Buckner

Research output: Contribution to journalArticle

59 Scopus citations

Fingerprint Dive into the research topics of 'North central cancer treatment group Phase i trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy